Hand eczema (HE) are non-infectious, inflammatory cutaneous lesions and belong to the most common skin disorder affecting the hands. In a substantial number of patients, HE can develop into a chronic condition that remains active even after avoidance of contact with potentially damaging allergens and/or irritants.
Chronic hand Eczema (CHE) has been defined as either a long-lasting, relapsing course of HE, or HE unresponsive to standard treatment with emollients and topical corticosteroids for more than 3 months or the recurrence of symptoms two or more times within a year despite treatment. It seems more relevant to define CHE as an anatomoclinic syndrome with multifactorial origin.
DelveInsight’s “Chronic Hand Eczema Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Chronic Hand Eczema, historical and forecasted epidemiology as well as the Chronic Hand Eczema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Chronic Hand Eczema Market Analsyis
-
As per DelveInsight estimates, the total prevalent population of Chronic Hand Eczema in 7MM is 4,229,215 cases in 2017. The estimates showed a higher number of cases in females as compared to males
-
Among the 7MM, the United States accounts for the maximum number of CHE cases with 1,994,070 cases in 2017
-
Among the 5 European countries, Germany had the highest prevalent population of Chronic Hand Eczema, followed by France and the United Kingdom. On the other hand, Spain had the lowest prevalent population
-
As per DelveInsight assessments, the therapeutic market of Chronic Hand Eczema (CHE) in seven major markets was found to be USD 1,226.71 million in 2017
-
The United States accounts for the largest CHE market size, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain), and Japan
Chronic Hand Eczema Market
The Chronic Hand Eczema market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Chronic Hand Eczema market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
Chronic Hand Eczema Epidemiology
The Chronic Hand Eczema epidemiology section covers insights about historical and current Chronic Hand Eczema patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
Chronic Hand Eczema Drugs Uptake and Key Market Players
The Chronic Hand Eczema Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Hand Eczema market or expected to get launched in the market during the study period. The analysis covers Chronic Hand Eczema market uptake by drugs; patient uptake by therapies; and sales of each drug.
Key Benefits of Chronic Hand Eczema Market Report
-
Chronic Hand Eczema market report provides an in-depth analysis of Chronic Hand Eczema Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Chronic Hand Eczema market report will help in developing business strategies by understanding the Chronic Hand Eczema Market trends & developments, key players and future market competition that will shape and drive the Chronic Hand Eczema market in the upcoming years.
-
The Chronic Hand Eczema market report covers Chronic Hand Eczema current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Chronic Hand Eczema market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
For more details visit:
https://www.delveinsight.com/report-store/chronic-hand-eczema-market